These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 14124776)
1. [ON THE DEFENSIVE REFLEX ANTIPLASMIN SYSTEM IN THE BODY]. KUDRIASHOV BA; KALISHEVSKAIA TM Biull Eksp Biol Med; 1963 Sep; 56():29-33. PubMed ID: 14124776 [No Abstract] [Full Text] [Related]
2. [NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM]. KUDRIASHOV BA; ANDREENKO GV; KALISHEVSKAIA TM Probl Gematol Pereliv Krovi; 1964 Apr; 9():12-5. PubMed ID: 14195816 [No Abstract] [Full Text] [Related]
3. ENHANCEMENT OF FIBRINOLYSIS AND ANTAGONISM OF ANTIPLASMIN BY REVERSIBLE PLASMIN INHIBITORS. MAXWELL RE; LEWANDOWSKI V; NICKEL VS Life Sci (1962); 1965 Jan; 4():45-51. PubMed ID: 14257064 [No Abstract] [Full Text] [Related]
4. AN ACTIVE STEREO-ISOMER (TRANS-FORM) OF AMCHA AND ITS ANTIFIBRINOLYTIC (ANTIPLASMINIC) ACTION IN VITRO AND IN VIVO. OKAMOTO S; SATO S; TAKADA Y; OKAMOTO U Keio J Med; 1964 Dec; 13():177-85. PubMed ID: 14279228 [No Abstract] [Full Text] [Related]
5. INACTIVATION OF ANTIPLASMIN AND COMPLEMENT C1 IN HUMAN PLASMA RENDERED FIBRINOLYTIC BY SYNTHETIC ORGANIC COMPOUNDS. VONKAULLA KN Thromb Diath Haemorrh; 1963 Nov; 10():151-63. PubMed ID: 14081277 [No Abstract] [Full Text] [Related]
6. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation]. Kanamori N; Koiwa F; Uda S Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690 [No Abstract] [Full Text] [Related]
7. Exsistence and significance of a reflex-humoral antiplasmin system in the organism. KUDRJASHOV BA; KALISHEVSKA TM Nature; 1963 May; 198():763-4. PubMed ID: 13927331 [No Abstract] [Full Text] [Related]
8. [STUDY OF THE ANTIFIBRINOLYTIC PROPERTIES OF KUNITZ'S PANCREATIC INHIBITOR. (TESTS IN VITRO AND IN VIVO)]. GIBELLI A; SCARDI F Gazz Int Med Chir; 1963 Oct; 67():2105-16. PubMed ID: 14095279 [No Abstract] [Full Text] [Related]
9. Observations on fibrinolysis; plasminogen, plasmin, and antiplasmin content of human blood. MACFARLANE RG; PILLING J Lancet; 1946 Oct; 2(6425):562-5. PubMed ID: 21001709 [No Abstract] [Full Text] [Related]
13. [ON THE EFFECT OF BLOOD COAGULATION INHIBITORS AND FIBRINOLYSIS ON THE SANARELLI-SHWARTZMAN PHENOMENON]. HAUSTEIN KO; MARKWARDT F Thromb Diath Haemorrh; 1965 Mar; 13():60-4. PubMed ID: 14285979 [No Abstract] [Full Text] [Related]
14. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases]. Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516 [TBL] [Abstract][Full Text] [Related]
15. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance. Carpenter SL; Mathew P Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165 [TBL] [Abstract][Full Text] [Related]
16. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions. Nielsen VG Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952 [TBL] [Abstract][Full Text] [Related]
18. Studies on changes in parameters of the coagulation and fibrinolysis in association with extracorporeal shock wave lithotripsy. Umekawa T; Kohri K; Yamate T; Amasaki N; Ishikawa Y; Kurita T Urol Int; 1993; 50(3):159-63. PubMed ID: 8465483 [TBL] [Abstract][Full Text] [Related]
19. [REFLEX MECHANISM OF THE EFFECT OF HEPARIN]. LOMAZOVA KD; MARKOSIAN AA Biull Eksp Biol Med; 1964 Feb; 57():20-3. PubMed ID: 14165029 [No Abstract] [Full Text] [Related]
20. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)]. Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]